CAPITOL HILL STRATEGIES, LLC for AMGEN
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Medical/Disease Research/Clinical Labs MED
H.R. 6, 21st Century Cures Act, (multiple provisions including incentives for innovation to help expedite novel treatments and cures, enhancements to FDA capacity and resources, and promotion of precision therapies, potential offsets) Senate Innovations for Healthy Americans Act (bill number/text not yet available but likely multiple provisions similar to H.R. 6 including incentives for innovation to help expedite novel treatments and cures, enhancements to FDA capacity and resources, and promotion of precision therapies, potential offsets) S. 1878, Advancing Hope Act of 2015 legislation that amends the Federal Food, Drug, and Cosmetic Act to expand the priority review voucher program for rare pediatric diseases to include treatments for sickle cell disease and pediatric cancers.
| Lobbyist | Covered position, as disclosed |
|---|---|
| CHARLES M BRAIN | Asst. to the President, Dp.Chief Staff W&M Cmte |
| HEATHER MCHUGH | Legislative Director, Sen. Chuck Schumer |
| BEAU` SCHUYLER | LD-CongTanner,LD-Cong.McIntyre,SA-CongRose |
| A. J. WOJCIAK | Senior Legislative Asst., Cong. Earl Pomeroy |
Copyright/Patent/Trademark CPT
S. 1137, Protecting American Talent and Entrepreneurship Act of 2015 (Inter partes review provisions and other provisions relating to patents covered by Hatch-Waxman and Biologics Price Competition and Innovation Act (BPCIA). H.R. 9, Innovation Act (Inter partes review provisions and other provisions relating to patents covered by Hatch-Waxman and Biologics Price Competition and Innovation Act (BPCIA).
| Lobbyist | Covered position, as disclosed |
|---|---|
| CHARLES M BRAIN | Asst. to the President, Dp.Chief Staff W&M Cmte |
| HEATHER MCHUGH | Legislative Director, Sen. Chuck Schumer |
| BEAU` SCHUYLER | LD-CongTanner,LD-Cong.McIntyre,SA-CongRose |
| A. J. WOJCIAK | Senior Legislative Asst., Cong. Earl Pomeroy |
Medicare/Medicaid MMM
Potential legislation or legislative provisions relating to Medicare Part D and the establishment of a Medicaid style mandatory rebate on prescription drugs CMS proposed rule potential and potential legislation that includes provisions that would alter payment policies under Medicare Part B for drugs and biologics
| Lobbyist | Covered position, as disclosed |
|---|---|
| CHARLES M BRAIN | Asst. to the President, Dp.Chief Staff W&M Cmte |
| HEATHER MCHUGH | Legislative Director, Sen. Chuck Schumer |
| BEAU` SCHUYLER | LD-Cong Tanner, LD-Cong McIntyre, SA-Cong Rose |
| A. J. WOJCIAK | Senior Legislative Asst., Cong. Earl Pomeroy |
Support LegiList
This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.